Insider trades

David Michael Johnson, Director of Zentalis Pharmaceuticals ZNTL, has filed 14 purchases and 0 sales on the open market. The latest trade was on 06/16.

David Michael Johnson

Director
First filing
23/01/09
Trades
26 trades
Buys / sales
14 / 0
12-month net buying
No record
Last trade
06/16

Trading activity

Transactions

Trade type
Open-market buy25/05/1625/05/2020,000 sh$4.90$98,000+13.7%
Open-market buy23/11/1023/11/1317,000 sh$9.88$167,960+13.3%
AURA
Open-market buy23/11/07–23/11/0823/11/09199,601 sh6 trades$7.19avg.$1,434,987.3No record
AURA
Open-market buy23/10/03–23/10/0423/10/0520,066 sh2 trades$8.38avg.$168,178.26+66.9%
AURA
Open-market buy23/01/05–23/01/0623/01/092,000 sh4 trades$10.41avg.$20,811.04+12.5%